Diabetes drug raises bone fracture risk in older women
February 11th, 2010 - 3:12 pm ICT by ANIWashington, Feb 11 (ANI): Women with type 2 diabetes who take a commonly prescribed class of medications to treat insulin resistance may be at a higher risk for developing bone fractures, Henry Ford Hospital study has found.
As per the study’s results, after taking a thiazolidinedione (TZD) for one year, women are 50 percent more likely to have a bone fracture than patients not taking TZDs. And those at the greatest risk for fractures from TZD use are women older than 65.
“Older women are already at a higher risk of osteoporosis and osteoporosis-related fractures, which might explain why they appeared to be the most affected by TZDs,” says study senior author L. Keoki Williams, M.D., MPH, Center for Health Services Research and Department of Internal Medicine at Henry Ford Hospital.
The study appears in this month’s issue of The Journal of Clinical Endocrinology & Metabolism. (ANI)
- Popular diabetes drugs 'increase risk for fractures in patients' - Jul 30, 2010
- Long-term use of osteoporosis drugs raises risk of fractures - Feb 23, 2011
- Popular class of diabetes drugs doubles fractures risk in women, finds Indian-origin boffin - Dec 10, 2008
- Fracture prone? Blame your genes - Apr 22, 2012
- No link between diabetes drug and rise in heart attacks - Jun 30, 2010
- Thinning of bones linked to heart failure - Feb 03, 2012
- Elderly can blame low sodium for fractures and falls - Nov 21, 2010
- Cells coordinate to promote exercise - Sep 20, 2011
- Diabetes or lipid-lowering medications may help treat addiction - Apr 06, 2011
- Why common drugs can lead to broken bones - Jun 09, 2010
- HIV-infected postmenopausal women at increased bone fracture risk - Jan 06, 2010
- Bones may have bigger role in diabetes than believed - Jul 23, 2010
- Human trial of promising new osteoporosis drug to be launched - Jan 15, 2010
- Why a class of diabetes drugs boosts weight gain - May 02, 2011
- Side effects of popular diabetes drugs described - May 04, 2011
Tags: amp, bone fracture, bone fractures, diabetes, diabetes drug, ford, fracture risk, health services research, henry ford, henry ford hospital, insulin resistance, internal medicine, keoki williams, medications, medicine, metabolism, older women, osteoporosis, type 2 diabetes, tzd